These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Boosting immune system against cancer by melatonin: A mechanistic viewpoint. Mortezaee K; Potes Y; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Najafi M; Farhood B Life Sci; 2019 Dec; 238():116960. PubMed ID: 31629760 [TBL] [Abstract][Full Text] [Related]
6. Melatonin, immune function and cancer. Srinivasan V; Pandi-Perumal SR; Brzezinski A; Bhatnagar KP; Cardinali DP Recent Pat Endocr Metab Immune Drug Discov; 2011 May; 5(2):109-23. PubMed ID: 22074586 [TBL] [Abstract][Full Text] [Related]
7. Oncostatic action of melatonin: facts and question marks. Pawlikowski M; Winczyk K; Karasek M Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():24-9. PubMed ID: 12019348 [TBL] [Abstract][Full Text] [Related]
8. Melatonin, a natural programmed cell death inducer in cancer. Sánchez-Hidalgo M; Guerrero JM; Villegas I; Packham G; de la Lastra CA Curr Med Chem; 2012; 19(22):3805-21. PubMed ID: 22612707 [TBL] [Abstract][Full Text] [Related]
9. The role of melatonin in immuno-enhancement: potential application in cancer. Miller SC; Pandi-Perumal SR; Esquifino AI; Cardinali DP; Maestroni GJ Int J Exp Pathol; 2006 Apr; 87(2):81-7. PubMed ID: 16623752 [TBL] [Abstract][Full Text] [Related]
10. Melatonin in cancer management: progress and promise. Jung B; Ahmad N Cancer Res; 2006 Oct; 66(20):9789-93. PubMed ID: 17047036 [TBL] [Abstract][Full Text] [Related]
11. The role of melatonin in the cells of the innate immunity: a review. Calvo JR; González-Yanes C; Maldonado MD J Pineal Res; 2013 Sep; 55(2):103-20. PubMed ID: 23889107 [TBL] [Abstract][Full Text] [Related]
12. Basic mechanisms involved in the anti-cancer effects of melatonin. Mediavilla MD; Sanchez-Barcelo EJ; Tan DX; Manchester L; Reiter RJ Curr Med Chem; 2010; 17(36):4462-81. PubMed ID: 21062257 [TBL] [Abstract][Full Text] [Related]
13. Immunological aspects of cancer chemotherapy. Zitvogel L; Apetoh L; Ghiringhelli F; Kroemer G Nat Rev Immunol; 2008 Jan; 8(1):59-73. PubMed ID: 18097448 [TBL] [Abstract][Full Text] [Related]
14. The validity of melatonin as an oncostatic agent. Panzer A; Viljoen M J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204 [TBL] [Abstract][Full Text] [Related]
15. Melatonin--a possible link between sleep and the immune system. Haimov I; Shochat T; Lavie P Isr J Med Sci; 1997 Apr; 33(4):246-50. PubMed ID: 9347872 [No Abstract] [Full Text] [Related]
16. Melatonin involvement in immunity and cancer. Fraschini F; Demartini G; Esposti D; Scaglione F Biol Signals Recept; 1998; 7(1):61-72. PubMed ID: 9641799 [TBL] [Abstract][Full Text] [Related]
17. Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors. Lu S; Zhang J; Liu D; Li G; Staveley-O'Carroll KF; Li Z; Wu JD Clin Cancer Res; 2015 Nov; 21(21):4819-30. PubMed ID: 26106076 [TBL] [Abstract][Full Text] [Related]
18. Melatonin-immune system relationships. Guerrero JM; Reiter RJ Curr Top Med Chem; 2002 Feb; 2(2):167-79. PubMed ID: 11899099 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the immune system by melatonin; implications for cancer therapy. Moslehi M; Moazamiyanfar R; Dakkali MS; Rezaei S; Rastegar-Pouyani N; Jafarzadeh E; Mouludi K; Khodamoradi E; Taeb S; Najafi M Int Immunopharmacol; 2022 Jul; 108():108890. PubMed ID: 35623297 [TBL] [Abstract][Full Text] [Related]
20. Melatonin: therapeutic and clinical utilization. Altun A; Ugur-Altun B Int J Clin Pract; 2007 May; 61(5):835-45. PubMed ID: 17298593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]